Pfizer is recalling intravenous drugs with floating matter in them, warning they could potentially kill weakened patients, after U.S. regulators had warned about the worries prior to the rec... Read more
At press time, the Food and Drug Administration was still in the process of conducting a very active and dynamic investigation into the source of the most recent Salmonella Typhimurium outbr... Read more
U.S. health officials have been reviewing a higher rate of deaths among patients treated with Eprex, a Johnson & Johnson anemia drug, in a German study of stroke patients. Sixteen perce... Read more
A consumer-advocacy group filed suit against MillerCoors LLC in an effort to have the company’s Sparks beverage removed from the Washington, D.C., market. This is the latest in the cam... Read more
The results of a nationwide study published in the Journal of Hospital Medicine revealed that nearly half (49%) of almost 500,000 hospital patients 65 and older have been prescribed one or m... Read more
A Manhattan federal judge has ruled that the U.S. Supreme Court’s recent ruling in Stoneridge Investment Partners v. Scientific-Atlanta Inc., doesn’t shield a Bristol-Myers Squib... Read more
The Food and Drug Administration has declined to approve an expanded use of Doribax, a Johnson & Johnson antibiotic, despite an advisory panel’s favorable recommendation. That was... Read more
U.S. drug regulators are investigating whether the cholesterol-lowering drug Vytorin might be linked to cancer. The U.S. Food and Drug Administration informed health-care professionals that... Read more
Pfizer Inc. has agreed to settle litigation with Canadian generic drug maker Apotex Inc. related to Pfizer’s cholesterol drug Lipitor. No details were provided by Pfizer but the compan... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.